We are thrilled to participate in the $161M Series B financing of Nuvig Therapeutics Inc. to test its first-in-class Fc fragment immunomodulator in Phase II studies across multiple autoimmune indications. https://lnkd.in/daHqyfhr
Global BioAccess Fund
Venture Capital and Private Equity Principals
New York, New York 196 followers
Accelerating novel science to create new medicines
About us
At the Global BioAccess Fund we partner with forward-thinking companies to create the medicines of tomorrow. We invest in transformative technologies that address unmet needs in oncology, cardiovascular, CNS, and rare diseases. We fund early-stage companies who need capital to support IND submission and clinical trials.
- Website
-
globalbioaccess.com
External link for Global BioAccess Fund
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2021
Locations
-
Primary
Get directions
880 3rd Avenue
New York, New York 10022, US